[15] Semaglutide also lowers blood glucose through its incretin mimetic action, particularly in patients with type 2 diabetes
Additionally, improved insulin sensitivitya beneficial effect of both semaglutide and weight losscan alter the hormonal milieu, further influencing menstrual patterns
It runs from July 1, 2026, through December 31, 2027, and it grew out of a deal the Trump administration struck in November with drugmakers Eli Lilly and Novo Nordisk to bring down the price of their obesity treatments
While primarily used for diabetes management and weight loss, research is ongoing into other potential applications of semaglutide
In the new study, researchers examined 30 studies on peer support for bipolar disorder, looking for patterns